Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Revvity Inc. (RVTY) vs Twist Bioscience Corporation (TWST)

Revvity Inc. and Twist Bioscience Corporation are both Diagnostics & Research companies. Revvity Inc. is the larger, with a market value of $16.8B against $12.4B — 1.4× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Revvity Inc. trades at 72.0×. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against 4.05%. Revvity Inc. has the higher net margin (8.16% vs −31.7%) and the higher return on invested capital (2.38% vs −30.8%). Across the 19 metrics below, Revvity Inc. leads on 12 and Twist Bioscience Corporation on 7.

Valuation

Metric RVTY TWST Diagnostics & Research median
P/E 71.96 n/m 33.95
P/S 5.79 26.49 4.87
P/B 2.33 25.66 3.12
Price to free cash flow 29.84 n/m 34.02
EV/EBITDA 24.55 n/m 25.20
EV/Sales 6.54 26.18 5.66
Earnings yield 1.39% (1.21%) (1.75%)
Free cash flow yield 3.35% (0.84%) (0.13%)

Profitability

Metric RVTY TWST Diagnostics & Research median
Gross margin 54.98% 51.97% 50.89%
Operating margin 12.32% (33.58%) (8.57%)
Net margin 8.16% (31.66%) (6.37%)
Free cash flow margin 19.58% (22.15%) 0.00%
Return on equity 3.21% (29.59%) (2.92%)
Return on assets 1.95% (20.78%) (6.71%)
Return on invested capital 2.38% (30.83%) 0.00%

Growth

Metric RVTY TWST Diagnostics & Research median
Revenue growth (TTM) 4.05% 19.19% 7.69%
EPS growth (last fiscal year) (5.91%) 63.89% —
Revenue growth, 5-year CAGR 1.41% 33.11% 7.40%
Net income growth, 5-year CAGR (19.82%) 0.00% 0.00%

Health

Metric RVTY TWST Diagnostics & Research median
Debt to equity 0.44 0.03 0.11
Current ratio 1.80 2.67 2.02
Net debt to EBITDA 3.00 1.95 0.78

Dividend

Metric RVTY TWST Diagnostics & Research median
Dividend yield 0.27% — 0.70%
Payout ratio 0.05 0.00 0.00

Size

Metric RVTY TWST Diagnostics & Research median
Market cap 16.81b 12.39b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack